These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 9472698)

  • 21. Combination chemoprevention of intestinal carcinogenesis in a murine model of familial adenomatous polyposis.
    Ignatenko NA; Besselsen DG; Stringer DE; Blohm-Mangone KA; Cui H; Gerner EW
    Nutr Cancer; 2008; 60 Suppl 1():30-5. PubMed ID: 19003578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BID mediates selective killing of APC-deficient cells in intestinal tumor suppression by nonsteroidal antiinflammatory drugs.
    Leibowitz B; Qiu W; Buchanan ME; Zou F; Vernon P; Moyer MP; Yin XM; Schoen RE; Yu J; Zhang L
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16520-5. PubMed ID: 25368155
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of the non-steroidal anti-inflammatory drug sulindac on colorectal adenomas of uncolectomized familial adenomatous polyposis.
    Matsumoto T; Nakamura S; Esaki M; Yao T; Iida M
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):251-7. PubMed ID: 16460482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment and survival study in the C57BL/6J-APC(Min)/+(Min) mouse with R-flurbiprofen.
    Wechter WJ; Murray ED; Kantoci D; Quiggle DD; Leipold DD; Gibson KM; McCracken JD
    Life Sci; 2000 Jan; 66(8):745-53. PubMed ID: 10680582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional response leading to tumorigenesis after sulindac in small and large intestine of mice with Apc mutations.
    Yang K; Fan K; Kurihara N; Shinozaki H; Rigas B; Augenlicht L; Kopelovich L; Edelmann W; Kucherlapati R; Lipkin M
    Carcinogenesis; 2003 Mar; 24(3):605-11. PubMed ID: 12663524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
    Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
    Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The comparative study of acetyl-11-keto-beta-boswellic acid (AKBA) and aspirin in the prevention of intestinal adenomatous polyposis in APC(Min/+) mice.
    Wang R; Wang Y; Gao Z; Qu X
    Drug Discov Ther; 2014 Feb; 8(1):25-32. PubMed ID: 24647155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response of Apc(min) and A33 (delta N beta-cat) mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
    Orner GA; Dashwood WM; Blum CA; Díaz GD; Li Q; Al-Fageeh M; Tebbutt N; Heath JK; Ernst M; Dashwood RH
    Mutat Res; 2002 Sep; 506-507():121-7. PubMed ID: 12351151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sulindac sulfone is most effective in modulating beta-catenin-mediated transcription in cells with mutant APC.
    Chang WC; Everley LC; Pfeiffer GR; Cooper HS; Barusevicius A; Clapper ML
    Ann N Y Acad Sci; 2005 Nov; 1059():41-55. PubMed ID: 16382042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemopreventive agents inhibit aberrant proliferation of the aneuploid phenotype in a colon epithelial cell line established from Apc 1638N [+/-] mouse.
    Katdare M; Kopelovich L; Telang N
    Ann N Y Acad Sci; 2001 Dec; 952():169-74. PubMed ID: 11795437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary chemoprevention of familial adenomatous polyposis with sulindac.
    Giardiello FM; Yang VW; Hylind LM; Krush AJ; Petersen GM; Trimbath JD; Piantadosi S; Garrett E; Geiman DE; Hubbard W; Offerhaus GJ; Hamilton SR
    N Engl J Med; 2002 Apr; 346(14):1054-9. PubMed ID: 11932472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary putrescine reduces the intestinal anticarcinogenic activity of sulindac in a murine model of familial adenomatous polyposis.
    Ignatenko NA; Besselsen DG; Roy UK; Stringer DE; Blohm-Mangone KA; Padilla-Torres JL; Guillen-R JM; Gerner EW
    Nutr Cancer; 2006; 56(2):172-81. PubMed ID: 17474863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemoprevention of familial adenomatous polyposis development in the APC(min) mouse model by 1,4-phenylene bis(methylene)selenocyanate.
    Rao CV; Cooma I; Rodriguez JG; Simi B; El-Bayoumy K; Reddy BS
    Carcinogenesis; 2000 Apr; 21(4):617-21. PubMed ID: 10753194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis.
    Stoner GD; Budd GT; Ganapathi R; DeYoung B; Kresty LA; Nitert M; Fryer B; Church JM; Provencher K; Pamukcu R; Piazza G; Hawk E; Kelloff G; Elson P; van Stolk RU
    Adv Exp Med Biol; 1999; 470():45-53. PubMed ID: 10709673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulindac treatment alters collagen and matrilysin expression in adenomas of ApcMin/+ mice.
    Guillen-Ahlers H; Buechler SA; Suckow MA; Castellino FJ; Ploplis VA
    Carcinogenesis; 2008 Jul; 29(7):1421-7. PubMed ID: 18499699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combinatorial chemoprevention of intestinal neoplasia.
    Torrance CJ; Jackson PE; Montgomery E; Kinzler KW; Vogelstein B; Wissner A; Nunes M; Frost P; Discafani CM
    Nat Med; 2000 Sep; 6(9):1024-8. PubMed ID: 10973323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of NAG-1/GDF15 in the inhibition of intestinal polyps in APC/Min mice by sulindac.
    Wang X; Kingsley PJ; Marnett LJ; Eling TE
    Cancer Prev Res (Phila); 2011 Jan; 4(1):150-60. PubMed ID: 21205743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model.
    Williamson T; Bai RY; Staedtke V; Huso D; Riggins GJ
    Oncotarget; 2016 Oct; 7(42):68571-68584. PubMed ID: 27612418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulindac in familial adenomatous polyposis.
    Levy R
    N Engl J Med; 2002 Aug; 347(8):615. PubMed ID: 12192027
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.